AstraZeneca Pharma gets CDSCO nod to import leukaemia drug Calquence 100 mg tablets
Drug firm, AstraZeneca Pharma India Ltd, on Friday (April 10), said it has received permission from the Central Drugs Standard Control Organisation (CDSCO) to import acalabrutinib tablets 100 mg, marketed as Calquence, for an additional indication in India. The approval was granted on April 9, 2026, by the CDSCO under the Directorate General of Health…
